Through engaging lectures, case studies, and virtual microscopy sessions,Masters of Pathology Series – Lung Pathology helps build and translate knowledge into realistic diagnostic scenarios. Course Director Lynette M. Sholl, MD, and her colleagues deliver in-depth coverage of topics like granulomatous diseases, vasculitis, multiple lung tumors, lung transplant pathology, pulmonary vascular pathology, benign mimics of lung cancer, and more. This CME course will help you to better:
Recognize common, uncommon mediastinal tumors including thymic neoplasms
Interpret the clinical implications of specific carcinoma diagnoses
Identify effective diagnostic and predictive biomarkers for NSCLC diagnosis
Differentiate between reactive and neoplastic proliferations of the lung and pleura
Understand the relevance of IHC, FISH, molecular tests for diagnosing malignant mesothelioma
Define appropriate biomarkers to select lung cancer patients for immunotherapy
* Date of Original Release: June 1, 2019 – Reviewed for Re-Release: June 1, 2022
LEARNING OBJECTIVES
At the conclusion of this activity, the participant will be able to:
Identify the pathologic and immunohistochemical features of common lung carcinomas and understand the clinical implications of specific carcinoma diagnoses.
Identify the crucial diagnostic and predictive biomarkers for non-small cell lung carcinomas and understand how to apply them in clinical practice.
Define appropriate biomarkers for selection of lung cancer patients for immunotherapy.
Distinguish between reactive and neoplastic proliferations of the lung and pleura.
Recognize common and uncommon mediastinal tumors including thymic neoplasms.
Recognize clinically significant interstitial changes in the lung in patients with and without prospectively recognized clinical and radiographic correlates.examinations